Literature DB >> 17965421

Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.

Manuel López-Brea1, Teresa Alarcón, Diego Domingo, Jazmín Díaz-Regañón.   

Abstract

OBJECTIVES: To determine the in vitro inhibitory effect of several Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
METHODS: The in vitro effect of 32 microorganisms against H. pylori clinical isolates was determined by a diffusion method. Time-kill assay was performed with two Staphylococcus spp. strains.
RESULTS: Anti-H. pylori activity was detected with Saccharomyces cerevisiae, Bacillus spp., 1 Enterococcus faecium and 2 Lactobacillus spp. against 7, 11, 1, 5 and 6 H. pylori strains tested. All Staphylococcus spp. showed an anti-H. pylori effect: one Staphylococcus auricularis and two Staphylococcus epidermidis against all H. pylori tested; Staphylococcus aureus, Staphylococcus hominis and S. auricularis against six, five and seven H. pylori strains; and two other coagulase-negative Staphylococcus against one H. pylori strain. An inhibitory effect was detected with one Escherichia coli against one H. pylori. Klebsiella pneumoniae, Salmonella spp. and Acinetobacter baumannii showed activity against four H. pylori strains, and Enterobacter cloacae and Stenotrophomonas maltophilia showed activity against 14 H. pylori isolates. No anti-H. pylori activity was detected with one Lactobacillus spp., two Lactococcus lactis, four Streptococcus spp., one Bacillus cereus, one E. faecium, one Enterococcus faecalis, one E. coli, Pseudomonas aeruginosa and Klebsiella oxytoca. Time-kill assay showed bactericidal activity at 24 h with the two Staphylococcus spp. strains tested.
CONCLUSIONS: Several strains of human pathogens or commensal bacteria are able to inhibit H. pylori growth in vitro and it is a strain-dependent phenomenon.

Entities:  

Mesh:

Year:  2007        PMID: 17965421     DOI: 10.1093/jac/dkm404

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori.

Authors:  Luc De Vuyst; Pascal Vincent; Eleftherios Makras; Frédéric Leroy; Bruno Pot
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

2.  Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer.

Authors:  Zeli Shen; JoAnn Dzink-Fox; Yan Feng; Sureshkumar Muthupalani; Anthony J Mannion; Alexander Sheh; Mark T Whary; Hilda R Holcombe; Blanca M Piazuelo; Luis E Bravo; Christine Josenhans; Sebastian Suerbaum; Keith T Wilson; Richard M Peek; Timothy C Wang; James G Fox
Journal:  mSphere       Date:  2022-02-09       Impact factor: 5.029

3.  Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis.

Authors:  Susana Delgado; Analy M O Leite; Patricia Ruas-Madiedo; Baltasar Mayo
Journal:  Front Microbiol       Date:  2015-01-14       Impact factor: 5.640

4.  Bacteriophages as potential new mammalian pathogens.

Authors:  George V Tetz; Kelly V Ruggles; Hua Zhou; Adriana Heguy; Aristotelis Tsirigos; Victor Tetz
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.